收费全文 | 4551篇 |
免费 | 327篇 |
国内免费 | 1篇 |
4879篇 |
2023年 | 23篇 |
2022年 | 49篇 |
2021年 | 88篇 |
2020年 | 58篇 |
2019年 | 65篇 |
2018年 | 94篇 |
2017年 | 90篇 |
2016年 | 156篇 |
2015年 | 201篇 |
2014年 | 222篇 |
2013年 | 311篇 |
2012年 | 370篇 |
2011年 | 352篇 |
2010年 | 226篇 |
2009年 | 193篇 |
2008年 | 287篇 |
2007年 | 301篇 |
2006年 | 262篇 |
2005年 | 248篇 |
2004年 | 211篇 |
2003年 | 190篇 |
2002年 | 196篇 |
2001年 | 42篇 |
2000年 | 21篇 |
1999年 | 37篇 |
1998年 | 61篇 |
1997年 | 25篇 |
1996年 | 37篇 |
1995年 | 45篇 |
1994年 | 23篇 |
1993年 | 39篇 |
1992年 | 26篇 |
1991年 | 22篇 |
1990年 | 15篇 |
1988年 | 12篇 |
1987年 | 21篇 |
1986年 | 15篇 |
1985年 | 16篇 |
1984年 | 15篇 |
1983年 | 15篇 |
1982年 | 14篇 |
1981年 | 17篇 |
1980年 | 17篇 |
1977年 | 10篇 |
1976年 | 12篇 |
1975年 | 16篇 |
1974年 | 10篇 |
1973年 | 10篇 |
1972年 | 11篇 |
1969年 | 8篇 |
Cisplatin has been extensively used in therapeutics for its broad-spectrum anticancer activity and frequently used for the treatment of solid tumors. However, it presents several side-effects and several cancers develop resistance. Combination therapy of cisplatin with poly (ADP-ribose) polymerase 1 (PARP1) inhibitors has been effective in increasing its efficacy at lower doses.
Methods and resultsIn this work, we have shown that the nitro-flavone derivative, 2-(4-Nitrophenyl)-4H-chromen-4-one (4NCO), can improve the sensitivity of cancer cells to cisplatin through inhibition of PARP1. The effect of 4NCO on cisplatin toxicity was studied through combination therapy in both exponential and density inhibited A375 melanoma cells. Combination index (CI) was determined from isobologram analysis. The mechanism of cell killing was assessed by lactate dehydrogenase (LDH) assay. Temporal nicotinamide adenine dinucleotide (NAD+) assay was done to show the inhibition of PARP1. We also performed in silico molecular modeling studies to know the binding mode of 4NCO to a modeled PARP1-DNA complex containing cisplatin-crosslinked adduct. The results from both in silico and in cellulo studies confirmed that PARP1 inhibition by 4NCO was most effective in sensitizing A375 melanoma cells to cisplatin. Isobologram analysis revealed that 4NCO reduced cell viability both in exponential and density inhibited A375 cells synergistically. The combination led to cell death through apoptosis.
ConclusionThe synthetic nitro-flavone derivative 4NCO effectively inhibited the important nuclear DNA repair enzyme PARP1 and therefore, could complement the DNA-damaging anticancer drug cisplatin in A375 cells and thus, could act as a potential adjuvant to cisplatin in melanoma therapy.
相似文献Coral cover and community structure in the Arabian Gulf have changed considerably in recent decades. Recurrent bleaching events have dramatically reduced the abundance of previously dominant Acropora corals and have given space to other more thermally resistant coral taxa. The loss of Acropora spp. has reduced reef structural complexity and associated biodiversity. Sir Bu Nair Island (SBN) is a nature reserve in the United Arab Emirates that sustains some of the last dense and extensive Acropora stands in the southern Gulf. This study investigated coral recruitment at a southern coral reef on SBN and examined larval dispersal and reef connectivity between SBN and other local and regional reefs through an agent-based model coupled with a 3D hydrodynamic model. Recruitment was surveyed with settlement tiles deployed from April to September 2019. Contrary to other reefs in the Gulf, we found that Acropora is indeed the major coral recruiter settling at SBN reefs, followed by Porites. The models indicate that SBN reefs are mostly self-seeding but also connected to other reefs in the Gulf. SBN can supply coral larvae to the neighbouring islands Siri and Abu Musa, and nearby reefs along with the north-eastern Emirates, Iranian coast and Strait of Hormuz. Findings highlight the importance of SBN to protect remnant populations of the locally almost extinct Acropora in a region where natural coral recovery is increasingly sparse.
相似文献